TRANSMEDICS GROUP INC (TMDX) Stock Income Statement
NASDAQ:TMDX - Nasdaq - US89377M1099 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 488.23M | 441.54M | 241.62M | 93.46M | 30.26M | |||
| Cost Of Goods | 197.88M | 179.46M | 87.53M | 28.19M | 9.10M | |||
| Gross Profit | 290.35M | 262.08M | 154.09M | 65.27M | 21.16M | |||
| Operating Expenses | 237.83M | 224.59M | 153.61M | 96.71M | 60.59M | |||
| Research and Development | 61.75M | 55.97M | 36.05M | 26.81M | 22.30M | |||
| Selling, General, and Administrative Expenses | 175.78M | 168.42M | 117.45M | 69.90M | 38.28M | |||
| Operating Income | 52.52M | 37.50M | 485.00K | -31.44M | -39.43M | |||
| Interest Income/Expense | -2.46M | -1.72M | 2.06M | -5.33M | -4.75M | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | -880.00K | |||
| Non Recurring Items | N/A | N/A | -29.21M | 600.00K | N/A | |||
| Income Before Taxes | 50.06M | 35.78M | -26.67M | -36.17M | -44.18M | |||
| Income Tax | 1.11M | 316.00K | -1.64M | 70.00K | 40.00K | |||
| Net Income | 48.95M | 35.46M | -25.03M | -36.23M | -44.22M | |||
| EBITDA | 74.11M | 57.25M | 8.66M | -27.96M | -37.61M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 1.30 | 1.01 | -0.77 | -1.23 | -1.60 | |||
| Non GAAP EPS | 1.36 | 1.01 | -0.77 | -1.25 | -1.61 | |||
| Statistics | ||||||||
| Gross Profit Margin | 59.47% | 59.36% | 63.77% | 69.84% | 69.93% | |||
| Profit Margin | 10.03% | 8.03% | -10.36% | -38.77% | -146.13% | |||
| Operating Profit Margin | 10.76% | 8.49% | 0.20% | -33.64% | -130.30% | |||
All data in USD